Tumor Marker-Based RecistTM is Superior to RECIST As Criteria to Predict the Long-Term Benefits of Targeted Therapy in Advanced Non-Small-cell Lung Cancer with Driver Gene Mutations

Kai Xiong,Yi Yang, Yanan Yang, Zhengbo Wang,Yun Liu, Hong Duo, Xinya Yuan, Yao Xiao,He Xiao,Xueqin Yang

Neoplasia（2024）

引用 0|浏览7

关键词

Non-small-cell lung cancer,Overall survival,Progression-free survival,RecistTM,RECIST

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要